BioSpace News Archive

Business

Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - July 09, 2024

July 10, 2024
·
3 min read
Drug Development

Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical development stage, highly selective third generation RXR nuclear receptor agonist compound, supporting its potential use for prevention and treatment of normal aging-related neurodegeneration, Parkinson’s disease, and Alzheimer’s disease

July 10, 2024
·
5 min read
Business

Emergent BioSolutions Continues to Drive Improved Financial Position as Part of Multi-Year Transformation Plan

July 10, 2024
·
4 min read
Business

Sutro Biopharma Appoints Dr. Barbara Leyman as Chief Business Development Officer

July 10, 2024
·
6 min read
Drug Development

Aktis Oncology Appoints Akos Czibere, MD, PhD, Chief Medical Officer

July 10, 2024
·
3 min read
Business

Sysmex America Announces Dan Zortman as New CEO

July 10, 2024
·
2 min read
Drug Development

ORLADEYO® (berotralstat) Approved in Peru

July 10, 2024
·
5 min read
Drug Development

Paragon Genomics Partners with Biosecure ID to Expand Access to CleanPlex® Technology in the UK and Ireland

July 10, 2024
·
4 min read
Business

Dentsply Sirona to Host Second Quarter Conference Call on July 31st

July 10, 2024
·
1 min read
Drug Development

Mitsubishi Tanabe Pharma America to Feature RADICAVA ORS® (edaravone) Real-World Data at 2024 ALS Nexus Conference

July 10, 2024
·
7 min read